🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NIH has released this brief yesterday re the START study we recently presented at IDWeek in Washington DC. A study started in 2008 that have had major impact on approach to treating persons infected with HIV globally. #INSIGHT #CPHIV hiv.gov/blog/early-hiv…

BIG DAY ⁦Migle Gabrielaite⁩ defended her stellar PhD thesis on Genomics of microbial pathogens in chronic infections. Congrats and thanks for your contribution to research and diagnostics at ⁦Rigshospitalet⁩

Morning seminar by ⁦Maha Farhat⁩ on Genotype to phenotype associations in infectious disease pathogens and translation to better diagnostics. Thanks to ⁦Maha Farhat⁩ ⁦SandraBreumAndersen⁩ Frank Aarestrup to serve in assessment committee of ⁦Migle Gabrielaite⁩ PhD

Jeg ser en del mænd her på platformen forsøge at bortforklare lønforskellen mellem mænd og kvinder. Faktum er dog er ca. 15% af forskellen er helt “uforklarlig” ifølge VIVEviden .Det tænker jeg skal være et fremtidigt fokusområde #dkpol

Dear ⁦DI - Dansk Industri⁩ You say that you lack qualified candidates. Tip: A better check for non-men candidates may help your supply 😂 #ligestilling #dkpol

Genomes of half of all bacterial isolates from infections are now being routinely sequenced at ⁦Rigshospitalet⁩ = 11,000 /year. Work led and presented by Karen Leth Nielsen at national clinical bacterial WGS meeting at ⁦Statens Serum Institut⁩

⚡️ On Nature Medicine - Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial Sumanta K. Pal, MD, FASCO Nazli Dizman #kidneycancer #immunotherapy nature.com/articles/s4159…

Excited to see this pre-print reporting a case series of phage therapy cases demonstrating improvements in pulmonary function and reduced Pseudomonas burden. Congrats Paul Turner Lab Jon Koff! #cysticfibrosis medrxiv.org/content/10.110…

Just released- we started START in 2008 - follow up ended 2021; main publication👇. Impressive and unique data set that will continue to provide #INSIGHT to HIV pathogenesis. Thanks to participants and congratulations to investigators. Live discussion 11 am in morning us eastern tomorrow👇

Congrats to the six males. (sorry, it is of course possible that the far majority of candidates or applicants were males)

Out now in Cell Host & Microbe: On-person adaptive evolution of Staphylococcus aureus during treatment for atopic dermatitis By Felix Key, Maria García-Romero, Tami Lieberman & colleagues. Felix Key Tami Lieberman cell.com/cell-host-micr…

Great talk by Sonia Aracil-Gisbert on bugs and plasmids persisting in sinks in ICUs. A lot of talks at #ECCMID2023 showing sinks/drains as major reservoirs fueling nosocomial outbreaks.

Excited to share our latest in PNASNews : The clinically prevalent 'clusters' of M. abscessus have a slower evolutionary/clock rate. Take home: just because clinical isolates are close genetically doesn't mean there was transmission pnas.org/eprint/BYUWJBF…

Out now Nature Medicine results of our #AcuteCare Australian Genomics study 🇦🇺 Huge national effort: 290 critically ill 👶 2.9 days to WGS result ⏱️ RNAseq+proteomics+extra analysis 🔍 👉54% diagnosed, major impacts on care 🏥 rdcu.be/dd4M6 🧵

Happy to be in Hamburg for #FEMS2023 Will present poster Monday 18h on our Microgem bioinformatics pipeline for “Tiered comparative genomic analysis of bacterial isolates”

This was a long time coming! We find that antibiotic tolerance precedes resistance in cystic fibrosis chronic infections - but as always, nature is messy: Only for some drugs and clone types academic.oup.com/evlett/advance… with Ashleigh Griffin Melanie Ghoul Rasmus Lykke Marvig Lars Jelsbak

Excellent colleagues 🙏from 🇮🇸🇸🇪🇫🇮🇳🇴🇩🇰 Scandinavian hospitals and genome centers to make already-in-production based recommendations for ## clinical bioinformatics ## #sundpol Danske Regioner Rigshospitalet Dept. of Molecular Medicine